Lymphoma, Low-Grade Completed Phase 1 / 2 Trials for Veltuzumab (DB05656)

Also known as: Low-Grade Lymphoma

IndicationStatusPhase
DBCOND0029914 (Lymphoma, Low-Grade)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00546793Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLTreatment